Virometix is offering co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses and other selected infectious diseases and chronic human diseases.
Virometix is also offering SVLP technology partnering and R&D collaborations in other application areas, including monoclonal antibody development, formulation of biologics and peptides and drug delivery.
For partnering enquiries, please contact us at [email protected]. Alternatively, you can meet us at the following upcoming conferences:
Grants & Awards
Our awards include the following